Literature DB >> 23774706

Intravitreal ranibizumab in the management of stage 2B Coats disease in a young adult Malay man.

Swee Sew Teh1, Amin Ahem, Mae-Lynn Catherine Bastion.   

Abstract

This paper describes a rare case of Coats disease with late presentation in a young adult. The condition improved with a combination of focal photocoagulation, cryotherapy and intravitreal ranibizumab.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23774706      PMCID： PMC3702914          DOI： 10.1136/bcr-2013-009697

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

Review 1.  Review: coats disease: the 2001 LuEsther T. Mertz lecture.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

2.  Management of Coats disease with bevacizumab in 2 patients.

Authors:  Pradeep Venkatesh; Subrata Mandal; Satpal Garg
Journal:  Can J Ophthalmol       Date:  2008-04       Impact factor: 1.882

3.  Resolution of macular edema in Coats' disease with intravitreal bevacizumab.

Authors:  Morteza Entezari; Alireza Ramezani; Ladan Safavizadeh; Nader Bassirnia
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

4.  Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.

Authors:  Shalini Kaul; Mahesh Uparkar; Kruti Mody; Jaydeep Walinjkar; Mihir Kothari; S Natarajan
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

5.  Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide.

Authors:  R R Jarin; S C B Teoh; T H Lim
Journal:  Eye (Lond)       Date:  2006-02       Impact factor: 3.775

6.  Coats' disease diagnosed in adulthood.

Authors:  Lindsay M Smithen; Gary C Brown; Alexander J Brucker; Lawrence A Yannuzzi; Christina M Klais; Richard F Spaide
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

7.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease.

Authors:  Mehmet Cakir; Osman Cekiç; O Faruk Yilmaz
Journal:  J AAPOS       Date:  2008-06       Impact factor: 1.220

9.  Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.

Authors:  Young Sun; Atul Jain; Darius M Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117

10.  Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.

Authors:  Jong Hwa Jun; Yu Cheol Kim; Kwang Soo Kim
Journal:  Korean J Ophthalmol       Date:  2008-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.